Nalaganje...
Oncolytic herpes simplex virus and temozolomide synergistically inhibit breast cancer cell tumorigenesis in vitro and in vivo
The oncolytic herpes simplex virus (HSV) G47Δ can selectively eliminate glioblastoma cells via viral replication and temozolomide (TMZ) has been clinically used to treat glioblastoma. However, the combined effect of G47Δ and TMZ on cancer cells, particularly on breast cancer cells, remains largely u...
Shranjeno v:
| izdano v: | Oncol Lett |
|---|---|
| Main Authors: | , , , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
D.A. Spandidos
2021
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7751368/ https://ncbi.nlm.nih.gov/pubmed/33376532 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3892/ol.2020.12360 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|